Satellite Banner
Technology Networks Header
Monday, December 22, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Randox Adiponectin Assay Gains CE Approval
Thursday, June 05, 2014
The Company’s technology has brought a superior option for Adiponectin assessment to the clinical diagnostics market.

Multiplicom Launches Two New Diagnostic Kits
Tuesday, June 03, 2014
Company aims for strong growth in the rapidly expanding molecular diagnostic market.

New Cancer Diagnostic Device
Thursday, May 29, 2014
Commercial launch of a new system to improve cancer diagnosis and treatment.

New Refrigerated Small Benchtop Centrifuge from Thermo Fisher Scientific
Thursday, May 22, 2014
Optimizing throughput, time and lab space for life science researchers and clinical laboratories.

Bio-Rad Expands Portfolio of PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, May 21, 2014
Company expands its collection of validated assays for mutation detection and copy number variation.

N-of-One to Provide Clinical Interpretation for Guardant360™ Tests
Monday, May 19, 2014
Breakthrough blood test enables next generation sequencing of solid tumor DNA.

Agilent Technologies Introduces New SureDirect Blood PCR Kit
Saturday, May 17, 2014
Enables PCR directly from blood without nucleic acid extraction.

Seegene Announces the World’s First Real-time PCR Technology
Tuesday, May 13, 2014
New “MDisc” technology breathes new life into real-time PCR by overcoming the challenge of “one channel, one Ct”.

Dako Launches Two Ready-to-Use Antibodies for Cancer Diagnosis
Wednesday, May 07, 2014
Company announces addition of Anti-CK 8/18 and Anti-TdT antibodies for routine diagnostic use.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 489
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn